The director of the Canadian Imperial Bank of Commerce (CM.TO) (TSE: CM) sells C $ 618,000.00 in stock
Canadian Imperial Bank of Commerce (CM.TO) (TSE: CM) (NYSE: CM) director Harry Kenneth Culham sold 5,000 shares in the company on Tuesday, March 9. The stock was sold at an average price of $ 123.60 for a total transaction of $ 618,000. Upon completion of the sale, the director now directly holds 2,330 shares in the company valued at approximately $ 287,988.
Harry Kenneth Culham also recently did the following deals:
- On Thursday, March 4th, Harry Kenneth Culham sold 10,000 shares in the Canadian Imperial Bank of Commerce (CM.TO). The shares were sold at an average price of $ 122.00 for a total transaction of $ 1,220,000.
CM stock traded at $ 0.24 on Friday and hit $ 124.20. 300,526 shares of the company’s shares were traded, compared to an average volume of 1,850,639. The Canadian Imperial Bank of Commerce has a 1-year low of $ 67.52 and a 1-year high of $ 125.00. The stock has a market capitalization of $ 55.62 billion and a price / earnings ratio of 13.55. The stock has a 50-day moving average of $ 114.82 and a 200-day moving average of $ 108.16.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 28th. On Monday, March 29th, registered investors will be paid a dividend of $ 1.46 per share. This equates to an annualized dividend of $ 5.84 and a yield of 4.70%. The ex-dividend date of this dividend is Friday March 26th. The payout ratio of the Canadian Imperial Bank of Commerce (CM.TO) is currently 63.86%.
A number of stock analysts recently rated the stock. Credit Suisse Group raised its target price for shares of the Canadian Imperial Bank of Commerce (CM.TO) in a research report on Friday, December 4th, from C $ 105.00 to C $ 108.00. Scotiabank raised its target price on shares of the Canadian Imperial Bank of Commerce (CM.TO) in a research note on Friday, February 26th, from C $ 139.00 to C $ 144.00. National Bank Financial raised its target price for shares in the Canadian Imperial Bank of Commerce (CM.TO) from C $ 126.00 to C $ 130.00 and rated the company in a research note on Friday, February 26th, with ” Outperform “. Fundamental Research raised its target price on shares of the Canadian Imperial Bank of Commerce (CM.TO) from CAD 115.36 to CAD 135.48 and gave the company a “Buy” rating in a research note on Tuesday, March 2nd. Finally, the Royal Bank of Canada raised its target price on shares in the Canadian Imperial Bank of Commerce (CM.TO) from C $ 130.00 to C $ 141.00 and rated the company in a research note on Friday, February 26th with “Outperform”. One research analyst gave the stock a hold rating and seven a buy rating. The company has a consensus rating of “Buy” and an average price target of $ 126.55.
And now it starts again, because a supply crisis could trigger a new lithium craze.
Canadian Imperial Bank of Commerce (CM.TO) company profile
Canadian Imperial Bank of Commerce, a diversified financial institution, offers a variety of financial products and services to retail, business, public, and institutional clients in Canada, the United States, and internationally. The company operates in four strategic businesses: Canadian Personal and Business Banking; Canadian Commercial Banking and Wealth Management; US
See also: How to Invest in an Index Fund
This instant message alert was generated through narrative science technology and financial data from MarketBeat to give readers the fastest, most accurate coverage possible. This story has been reviewed by the editorial staff of MarketBeat prior to publication. Please send questions or comments about this story to [email protected]
15 Healthcare Stocks Analysts Love
There are more than 200 healthcare companies traded on public markets. With the sheer number of drug companies, medical research companies, hospital systems, and other healthcare stocks, it can be difficult to identify which healthcare companies will outperform the market.
Fortunately, Wall Street’s brightest minds have already done this for us. Every year analysts make around 3,000 different recommendations for healthcare companies. Analysts don’t always get their buy recommendations correctly, but it pays to take a close look when multiple analysts from different brokers and research firms give buy and buy ratings for the same healthcare stocks.
This slideshow lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street stock analysts for the past 12 months.
Check out the “15 Healthcare Stocks Analysts Love”.